Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

BlackRock Science & Technology

Pfizer

Despite recent declines, the Dividend Harvesting Portfolio remains profitable, generating $1,908.79 in forward dividend income with a 23.38% return on invested capital. I believe the Fed's rate cuts are misplaced, and lower rates are needed to reduce housing costs and further curb inflation. I am bullish on 2025, expecting the portfolio to generate between $2,500-3,000 in dividend income, driven by reinvestments and weekly allocations.

Dividend Harvesting Portfolio Week 199: $19,900 Allocated, $1,908.79 In Projected Dividends

High-yield dividend stocks often catch investors' attention -- and for good reason. When established companies maintain larger-than-average dividend payments, they can provide both substantial current income and the potential for long-term appreciation.

Better Income Stock: Pfizer or Altria Group?

I went from recommending Altria as a Sell last to now being a Strong Buy, with strong assumptions for its future revenue and earnings. Altria has a margin of safety and its upside has not yet been priced in by the market as its gains follow its EPS linearly. I'm confident that Altria's top-line erosion can be curtailed and that it will swing into positive territory by the middle of next year.

Altria: I Couldn't Have Been More Wrong About This Stock (Rating Upgrade)

AllianceBernstein Hld

Ares Capital

Enterprise Products Partners

Starwood Property

Investors love dividend stocks, especially the ultra-high-yield variety because they offer a significant income stream and have massive total return potential.

5 of Wall Street's Favorite Ultra-High-Yield Dividend Stocks Are Top Picks for 2025

Chevron

Home Depot

Schwab US Dividend Equity ETF

Texas Instruments

The election results bring a new phase for the economy. While inflation has eased, prices remain high, and tackling them will be a challenge for President Trump. Despite rising bond yields and a tough economic environment, the market presents opportunities, especially in high-quality dividend stocks outside of tech's dominance. The market's current challenges create an ideal environment for strategic stock-picking, particularly in dividend growth stocks that come with moats, pricing power, healthy balance sheets, and stability.

Higher For Longer: Why Dividend Stocks Will Dominate 2025 And Beyond

Clearway Energy

MPLX

NextEra Energy

The Federal Reserve's slower-than-expected rate cuts led to a market sell-off, hitting high-yield stocks hard, but also creating buying opportunities. However, not all high-yielding dividend growth stocks that have pulled back in price are buys right now. I share one to avoid and two to buy.

7-8% Yields Are Crashing: 1 To Avoid And 2 To Buy

Ford Motor Company

Walgreens

"Dogs of the Dow" is a popular investing strategy. By buying shares of the highest-yielding stocks on the Dow Jones Industrial Average (^DJI 1.38%) market index, you can buy into top-quality companies whose shares are selling at a discount.

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

Altria (MO) reachead $52.99 at the closing of the latest trading day, reflecting a -0.49% change compared to its last close.

Altria (MO) Registers a Bigger Fall Than the Market: Important Facts to Note

Making Altria the largest position of your dividend portfolio could help you to increase its potential for generating dividend income and reducing volatility. This is due to Altria's Dividend Yield [FWD] of 7.46% and its low 24M Beta Factor of 0.16. In this article, I will demonstrate how you could build a $100,000 dividend portfolio across 2 ETFs and 10 dividend paying companies, while holding Altria as the largest portfolio position.

Strategically Building A $100,000 Dividend Portfolio, With Altria As Your Core Holding

Realty Income Corp

Neos Nasdaq-100 High Income ETF

This week, the markets saw mixed results with the S&P 500 declining by -0.52% and the Nasdaq climbing 0.47%, while inflation data solidified expectations for a Fed rate cut. The Dividend Harvesting Portfolio's profitability declined by -1.82%, but I remain bullish on the market and excited about potential tailwinds in 2025, including lower interest rates and corporate taxes. I added to positions in Realty Income, Ares Capital, and NEOS NASDAQ-100 High Income ETF, boosting my forward projected annualized dividend income to $1,898.52.

Dividend Harvesting Portfolio Week 198: $19,800 Allocated, $1,898.52 In Projected Dividends

Archer-Daniels-Midland Company

ConocoPhillips

CVS Health

Energy Transfer LP Unit

Halliburton

Johnson & Johnson

Coca-Cola

Lockheed Martin

Omnicom Group

PepsiCo

Prologis

Southern Company

AT&T

Exxon Mobil

The June/July, 2024 Fortune Magazine revealed 500 biggest U.S. companies by-revenue and profits. Arnold-research focused on 66 December industry-leaders using YCharts 12/13/24 data for Profits from 63. Those 63 Fortune 500 industry leaders (F500IL) were segmented into 21 business sectors ranging (alphabetically) from aerospace/defense to wholesalers. By yield, MO topped-all F500IL. Top-ten Yields from PEP, PLD, SO, XOM, ADM, T, UPS, CVS, ET, & MO, averaged 4.71% in December.

Of 63 Fortune500 Industry Leaders, 57 Pay Dividends, 38 Test 'Safer' & 1 Is Ideal To Buy

Zacks.com users have recently been watching Altria (MO) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Altria Group, Inc. (MO) is Attracting Investor Attention: Here is What You Should Know

Dow Inc

LyondellBasell Industries

In today's market, some of the S&P 500's highest-yielding stocks are offering attractive opportunities for both income and growth. These stocks stand out for their resilience and potential. I've researched three standout picks that provide solid dividends and the possibility of long-term growth. These stocks balance reliability and strong upside potential. With interest rates and inflation concerns, now may be the time to focus on dividend stocks that offer both steady income and the chance for meaningful appreciation.

3 Of The S&P 500's Highest-Yielding Stocks To Buy

BB Seguridade Participacoes SA

British American Tobacco

Philip Morris

I will demonstrate why I believe that Altria and BB Seguridade Participações S.A. could be attractive additions to your dividend portfolio. Both companies have an attractive Valuation, combine dividend income and dividend growth, and can help you decrease the volatility of your dividend portfolio. While Altria offers a Dividend Yield [FWD] of 7.30%, BB Seguridade Participações S.A.'s stands at 8.64%. Both companies have also shown significant dividend growth in recent years.

If I Could Only Buy 2 High Dividend Yield Companies In December 2024: Both Yield Above 7%

Altria (MO -0.13%) is a consumer staples giant with a growing dividend and a huge 7.4% dividend yield. That looks like a big opportunity for income investors, given that the S&P 500 is only yielding 1.2% and the average consumer staples stock just 2.5%.

Could Buying Altria Stock Today Set You Up for Life?

MO's turnaround from the Juul fiasco has been highly successful indeed, as observed in the growing NJOY sales across devices/ consumables and expanding retail share. PM ZYN's ongoing shortage has also been a boon, as observed in on!'s high double digit volume growth and oral tobacco market share in the US. MO's prospects are also significantly aided by the promising Vision and 2028 Enterprise Goals, funded through $600M in cumulative cost savings from the Optimize & Accelerate initiative.

Altria's Strategic Turnaround In Progress - More Upside Likely Ahead

Black Hills

Northwest Natural Gas

Universal Corp

Dividend stocks are a favorite among investors for good reason.

The Highest Yielding Dividend Kings Are the Perfect Gift Under the Tree This Year

Carlisle Companies

Gorman-Rupp

Kimberly-Clark

Target

First Financial

Tompkins Financial

T. Rowe Price Group

The S&P is up almost 30% this year, and many investors are worried about an impending crash. PEGY (PE divided by growth and yield) ratio combines yield, growth, quality and value, creating the potential for excellent long-term returns and income growth while outperforming the S&P. These low PEGY aristocrats boast a 4% yield, A-credit rating, 43-year dividend growth streak, 9% earnings growth, and a 13% long-term return potential, making them exceptional potential investments.

10 High-Yield Dividend Aristocrats For Growth And Bargain Hunters

AbbVie

California Water Service Group

Con Ed

Fortis

Hormel Foods

Kenvue

Middlesex Water

National Fuel Gas

PPG Industries

SJW Group

Stanley Black & Decker

"A Dividend King [is] a stock with 50 or more consecutive years of dividend increases." - suredividend.com. 53 Divided Kings, screened as of December 11, 2024, represented all eleven Morningstar Sectors. Broker-estimated top-ten net gains ranged from 14.79% to 25.23%, topped by SJW and SWK. By yield, MO topped all the Kings. Top-ten yields from ABBV, ADM, SWK, FRT, FTS, BKH, NWN, CDUAF, UVV, and MO averaged 4.67%.

Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends

News for Altria Stock (MO)